Low-Dose Adjuvant Aspirin Decreases Incidence of Recurrence Among Patients with Resected PI3K-Altered CRC By Ogkologos - September 30, 2025 162 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ALASCCA study Source RELATED ARTICLESMORE FROM AUTHOR No OS Improvement with CDK4/6 Inhibitors Used in First- Compared with Second-Line Treatment in Patients with HR-positive, HER2-negative ABC Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours Rare Disease Day 2026: Advancing equity for people living with rare cancers in Europe MOST POPULAR Only a Quarter of Phase III Studies Demonstrated Improved QoL in... July 18, 2022 Cancer in My Community: Expanding Access to Genetic Testing in Mexico September 1, 2020 Zantac Contains A Cancer-Causing Chemical And Now Breast Cancer Patients Are... September 30, 2019 Boy Battling Cancer Becomes Honorary Police Officer, Sworn In To 45... January 15, 2022 Load more HOT NEWS FDA Approves Lutetium Lu 177 Vipivotide Tetraxetan for Metastatic Castration-Resistant Prostate... Incidence of Colorectal, Breast, Kidney, Pancreatic, and Uterine Cancers is Increasing... Mom Goes From Worried To Mortified After Finding Dark Brown Spot... Withdrawal of the Application to Change the EMA Marketing Authorisation for...
